-
Ресурс РМЭБ
Единая база данных, объединяющая электронные ресурсы вузов Казахстана
Подробнее -
-
Генетическая паспортизация населения – новая технология профилактики и реабилитации в медицине
УДК:
614.2+575.191-616.1-006
Автор статьи:
Акильжанова А.Р.
Место работы автора:
РГП «Национальный центр биотехнологии Республики КазахстанГосударственный медицинский университет
Название журнала:
Терапевтический вестник
Год выпуска:
2010
Номер журнала:
1 спец. выпуск
Страницы:
с. 42-44
Список литературы:
1. Watson JD. The Human Genome Project: past, present and future. Science. 1990,248: 44-49.
2. Jordan E. The Human Genome Project: where did it come from? Where is it going? Am JHum Genet. 1992,51:1-6.
3. Hoffman EP. The evolving genome project: current and future impact. Am J Hum Genet. 1994,54:129-136.
4. Richards B, Skoletsky J, Shuber AP, et al. Multiplex PCR amplification from the CFTR gene using DNA prepared from buccal brushes/swabs. Hum Mol Genet. 1993,2:159-163.
5. Pritchard DJ, Korf BR. Medical Genetics at glance. Oxford, Blackwell Publishing, 2009, 200 p.
6. Holtzman NA. Proceed with Caution: Predicting Genetic Risks in the Recombinant DNA Era. Baltimore, Md: Johns Hopkins University Press, 1989.
7. Hubbard R, Wald E. Exploding the GeneMyth. Boston, Mass: Beacon Press, 1993.
8. Khoury MJ, Beaty TH, Cohen BH. Fundamentals of Genetic Epidemiology. New York, NY: Oxford University Press, 1993.
9. Brookes AJ. The essence of SNP. Review. Gene 1999,234(2):177-186.
10. Баранов В.С., Баранова Е.В., Иващенко Т.Э., Асеев М.В.Геном человека и гены предрасположенности. Введение в предиктивную медицину.—СПб: Интермедика, 2000.— 271 с.
11. Святова С. Медико-генетическая служба Республики Казахстан. Материалы I Республиканского съезда медицинских генетиков Казахстана , 2009, с 12-14.
12. Zak I, Niemiec P, Sarecka B, Balcerzyk A, Ciemniewski Z, Rudowska E, Dylag S.Carrier-state of D allele in ACE gene insertion/deletion polymorphism is associated with coronary artery disease, in contrast to the C677-->T transition in the MTHFR gene. Acta Biochim Pol. 2003,50(2):527-34.
13. Gruchala M, Ciecwierz D, Ochman K, Wasag B, Koprowski A, WojtowiczA, Dubaniewicz W, Targonski R, Sobiczewski W, GrzybowskiA, Romanowski P, Limon J, Rynkiewicz A.Left ventricular size, mass and function in relation to angiotensin-converting enzyme gene and angiotensinII type 1 receptor gene polymorphisms in patients with coronary artery disease. Clin Chem Lab Med. 2003 Apr, 41(4):522-8.
14. Montgomery H, Clarkson P, Bornard M et al. Angiothensinconverting enzyme gene insertion/deletion polymorphism and response to physical training. Lancet 1999,53:541-545.
15. Lee CH, Hankey GJ, Ho WK, Eikelboom JW. Venous thromboembolism: diagnosis and management of pulmonary embolism. Review. Med J Aust 2005,182(11):569-574.
16. Xin XY, Ding JQ, Chen SD.Apolipoprotein e promoter polymorphisms and risk of Alzheimer's disease: evidence from meta-analysis. J Alzheimers Dis. 2010 Jan,19(4):1283-94.
17. Miller DP, Neuberg D, de Vivo I, Wain JC, Lynch TJ, Su L, Christiani DC. Smoking and the risk of lung cancer: susceptibility with GSTP1 polymorphisms. Epidemiology 2003,14(5):545-551.
18. Tempfer CB, Schneeberger C, Huber JC.Applications of polymorphisms andpharmacogenomicsin obstetrics andgynecology.Pharmacogenomics. 2004 Jan,5(1):57-65.
19. Olivier M, Hollstein M, Hainaut P.TP53 Mutations in Human Cancers: Origins, Consequences, and Clinical Use.Cold Spring Harb Perspect Biol. 2010 Jan,2(1):a001008.
20. Medeiros R, Vasconcelos A, Costa S, Pinto D, Morais A, Oliveira J, Lopees C.Steroid hormone genotypes ARStuI and ER325 are linked to the progression of human prostate cancer. Cancer Genet Cytogenet. 2003 Mar,141(2):91-6.
21. Официальный сайт Всемирной организции здравоохранения - http:// www. who.int/whosis/en/
1. Watson JD. The Human Genome Project: past, present and future. Science. 1990,248: 44-49.
2. Jordan E. The Human Genome Project: where did it come from? Where is it going? Am JHum Genet. 1992,51:1-6.
3. Hoffman EP. The evolving genome project: current and future impact. Am J Hum Genet. 1994,54:129-136.
4. Richards B, Skoletsky J, Shuber AP, et al. Multiplex PCR amplification from the CFTR gene using DNA prepared from buccal brushes/swabs. Hum Mol Genet. 1993,2:159-163.
5. Pritchard DJ, Korf BR. Medical Genetics at glance. Oxford, Blackwell Publishing, 2009, 200 p.
6. Holtzman NA. Proceed with Caution: Predicting Genetic Risks in the Recombinant DNA Era. Baltimore, Md: Johns Hopkins University Press, 1989.
7. Hubbard R, Wald E. Exploding the GeneMyth. Boston, Mass: Beacon Press, 1993.
8. Khoury MJ, Beaty TH, Cohen BH. Fundamentals of Genetic Epidemiology. New York, NY: Oxford University Press, 1993.
9. Brookes AJ. The essence of SNP. Review. Gene 1999,234(2):177-186.
10. Баранов В.С., Баранова Е.В., Иващенко Т.Э., Асеев М.В.Геном человека и гены предрасположенности. Введение в предиктивную медицину.—СПб: Интермедика, 2000.— 271 с.
11. Святова С. Медико-генетическая служба Республики Казахстан. Материалы I Республиканского съезда медицинских генетиков Казахстана , 2009, с 12-14.
12. Zak I, Niemiec P, Sarecka B, Balcerzyk A, Ciemniewski Z, Rudowska E, Dylag S.Carrier-state of D allele in ACE gene insertion/deletion polymorphism is associated with coronary artery disease, in contrast to the C677-->T transition in the MTHFR gene. Acta Biochim Pol. 2003,50(2):527-34.
13. Gruchala M, Ciecwierz D, Ochman K, Wasag B, Koprowski A, WojtowiczA, Dubaniewicz W, Targonski R, Sobiczewski W, GrzybowskiA, Romanowski P, Limon J, Rynkiewicz A.Left ventricular size, mass and function in relation to angiotensin-converting enzyme gene and angiotensinII type 1 receptor gene polymorphisms in patients with coronary artery disease. Clin Chem Lab Med. 2003 Apr, 41(4):522-8.
14. Montgomery H, Clarkson P, Bornard M et al. Angiothensinconverting enzyme gene insertion/deletion polymorphism and response to physical training. Lancet 1999,53:541-545.
15. Lee CH, Hankey GJ, Ho WK, Eikelboom JW. Venous thromboembolism: diagnosis and management of pulmonary embolism. Review. Med J Aust 2005,182(11):569-574.
16. Xin XY, Ding JQ, Chen SD.Apolipoprotein e promoter polymorphisms and risk of Alzheimer's disease: evidence from meta-analysis. J Alzheimers Dis. 2010 Jan,19(4):1283-94.
17. Miller DP, Neuberg D, de Vivo I, Wain JC, Lynch TJ, Su L, Christiani DC. Smoking and the risk of lung cancer: susceptibility with GSTP1 polymorphisms. Epidemiology 2003,14(5):545-551.
18. Tempfer CB, Schneeberger C, Huber JC.Applications of polymorphisms andpharmacogenomicsin obstetrics andgynecology.Pharmacogenomics. 2004 Jan,5(1):57-65.
19. Olivier M, Hollstein M, Hainaut P.TP53 Mutations in Human Cancers: Origins, Consequences, and Clinical Use.Cold Spring Harb Perspect Biol. 2010 Jan,2(1):a001008.
20. Medeiros R, Vasconcelos A, Costa S, Pinto D, Morais A, Oliveira J, Lopees C.Steroid hormone genotypes ARStuI and ER325 are linked to the progression of human prostate cancer. Cancer Genet Cytogenet. 2003 Mar,141(2):91-6.
21. Официальный сайт Всемирной организции здравоохранения - http:// www. who.int/whosis/en/
Электронный вариант:
скачать
Последние Новости
- 28.11.2012
Казахстанская общенациональная пробная подписка на IEEE/IET
- 20.12.2011
В шаге от цели «Smart»
- 20.12.2011
Инновационный прорыв региона